Handelsbanken Fonder AB Acquires 14,919 Shares of Cardinal Health, Inc. $CAH

Handelsbanken Fonder AB lifted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 12.5% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 133,971 shares of the company’s stock after buying an additional 14,919 shares during the period. Handelsbanken Fonder AB owned about 0.06% of Cardinal Health worth $31,826,000 as of its most recent filing with the SEC.

Several other large investors have also bought and sold shares of CAH. Vanguard Group Inc. raised its stake in Cardinal Health by 2.0% during the fourth quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock worth $6,461,179,000 after acquiring an additional 617,775 shares in the last quarter. State Street Corp boosted its stake in shares of Cardinal Health by 1.8% in the 4th quarter. State Street Corp now owns 12,509,230 shares of the company’s stock valued at $2,570,647,000 after purchasing an additional 221,497 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Cardinal Health by 0.7% in the 4th quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company’s stock valued at $1,336,750,000 after purchasing an additional 43,924 shares in the last quarter. Wellington Management Group LLP grew its holdings in shares of Cardinal Health by 153.2% during the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after purchasing an additional 3,511,579 shares during the last quarter. Finally, Norges Bank acquired a new position in Cardinal Health during the 4th quarter worth approximately $790,344,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Earnings beat expectations: Fourth-quarter non-GAAP EPS was $2.91, well above the $2.42 analyst consensus and up from $2.08 a year earlier. Revenue rose 6% year over year to $63.7 billion, although it fell short of estimates near $65.15 billion. CAH Q4 Earnings Beat on Pharma Strength, Revenues Miss, Stock Up
• Positive Sentiment: Above-consensus fiscal 2027 guidance: Cardinal Health forecast adjusted EPS of $12.40 to $12.60, representing 13% to 15% growth and exceeding the $12.05 consensus. Management cited continued strength in specialty pharmaceuticals. Cardinal Health forecasts full-year profit above estimates on specialty drug strength
• Positive Sentiment: Large buyback authorization: The board approved an additional $5 billion for share repurchases, following $1.4 billion of buybacks completed during fiscal 2026. The authorization could support EPS growth and shareholder returns.
• Positive Sentiment: Growth in cell- and gene-therapy logistics: Cardinal added two commercialization agreements and now exclusively serves nearly half of the cell- and gene-therapy market, a higher-margin growth opportunity than traditional drug distribution. Cardinal Health Says It Now Exclusively Serves Nearly Half The Cell-And-Gene Therapy Market
• Positive Sentiment: Dividend maintained: Cardinal Health declared a quarterly dividend of $0.5158 per share, payable October 15 to shareholders of record October 1. Cardinal Health Board of Directors Approves Quarterly Dividend
• Neutral Sentiment: Mixed quarter and valuation concerns: The revenue shortfall and weakness in Global Medical Products and Distribution tempered the results. About $0.31 of quarterly adjusted EPS benefited from a one-time tariff refund, while the stock’s recent rally and elevated valuation may encourage profit-taking.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. JPMorgan Chase & Co. dropped their price objective on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a research note on Monday, May 4th. UBS Group upped their price target on shares of Cardinal Health from $260.00 to $274.00 and gave the stock a “buy” rating in a report on Monday, July 20th. Citigroup increased their price target on Cardinal Health from $245.00 to $265.00 and gave the company a “buy” rating in a research note on Friday, July 24th. Morgan Stanley raised their price objective on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a report on Tuesday, April 28th. Finally, Bank of America boosted their price objective on Cardinal Health from $240.00 to $260.00 and gave the stock a “buy” rating in a research report on Thursday, July 2nd. Fifteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $252.87.

Cardinal Health Trading Up 1.2%

Shares of CAH stock opened at $240.08 on Wednesday. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $258.30. The stock has a market cap of $56.23 billion, a price-to-earnings ratio of 36.71, a PEG ratio of 1.16 and a beta of 0.49. The stock has a 50-day moving average of $228.37 and a 200-day moving average of $216.66.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, topping analysts’ consensus estimates of $2.42 by $0.49. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. During the same period in the previous year, the firm earned $2.08 earnings per share. The firm’s quarterly revenue was up 5.8% on a year-over-year basis. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Sell-side analysts forecast that Cardinal Health, Inc. will post 10.77 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be given a $0.5158 dividend. The ex-dividend date is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s payout ratio is 31.50%.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.